BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Argus Health
Fish and Richardson
Federal Trade Commission

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,169,238

« Back to Dashboard

Which drugs does patent 9,169,238 protect, and when does it expire?

Patent 9,169,238 protects EDARBYCLOR and is included in one NDA.

This patent has twenty-five patent family members in twenty-four countries.

Summary for Patent: 9,169,238

Title:Solid pharmaceutical composition
Abstract: The present invention relates to a solid preparation containing a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof, a pH control agent and a diuretic, which is superior in the stability and dissolution property of the compound represented by the formula (I) and the diuretic. ##STR00001##
Inventor(s): Tanoue; Yutaka (Osaka, JP), Nomura; Junya (Osaka, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:12/737,612
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Arbor Pharms LlcEDARBYCLORazilsartan kamedoxomil; chlorthalidoneTABLET;ORAL202331-001Dec 20, 2011RXYesNo► Subscribe► Subscribe► SubscribeY
Arbor Pharms LlcEDARBYCLORazilsartan kamedoxomil; chlorthalidoneTABLET;ORAL202331-002Dec 20, 2011RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 9,169,238

PCT Information
PCT FiledJuly 29, 2009PCT Application Number:PCT/JP2009/063833
PCT Publication Date:February 04, 2010PCT Publication Number: WO2010/013835

International Patent Family for Patent: 9,169,238

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2732018► Subscribe
China102164918► Subscribe
Colombia6341633► Subscribe
Costa Rica20110111► Subscribe
Dominican RepublicP2011000032► Subscribe
Eurasian Patent Organization201170273► Subscribe
EcuadorSP11010856► Subscribe
European Patent Office2310385► Subscribe
Israel210819► Subscribe
Japan2011529444► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: